Epithalon Oral Bioavailability Epithalon may be especially suited to oral formulations due to its small size, which enables: Micro capsular delivery Easy penetration of cell membranes and the blood-brain barrier Lower susceptibility to enzymatic degradation in the digestive tract Research in this area is ongoing
For patients on broader longevity or optimization protocols, GHK-Cu injections may also be combined with NAD+ therapy, BPC-157, or other peptides depending on their clinical goals
Drug Side Effect Mitigation Animal studies suggest BPC-157 may counteract adverse effects of certain pharmaceuticals, particularly NSAIDs, neuroleptics, and prokinetics
Contents per vial: BPC-157 5mg + TB-500 (Thymosin Beta-4 fragment) 5mg
It is quick, it is effective, and yes, you will feel the difference